Serum relaxin in patients with hydatidiform mole

Area of Science:

• Reproductive Endocrinology
• Maternal-Fetal Medicine
• Hormone Regulation

Background:

• Human chorionic gonadotropin (hCG) is a key regulator of relaxin secretion.
• The secretory pattern of relaxin in hydatidiform mole pregnancies remains understudied.
• Hydatidiform mole is characterized by significantly elevated hCG levels compared to normal pregnancy.

Purpose of the Study:

• To investigate the relationship between hCG and relaxin secretion in hydatidiform mole.
• To compare relaxin, progesterone, and hCG levels before and after mole evacuation.
• To elucidate the source and regulation of relaxin in molar pregnancy.

Main Methods:

• Radioimmunoassay (RIA) was used to measure serum levels of relaxin, progesterone, and hCG.
• Measurements were taken in patients with hydatidiform mole before and after surgical evacuation.
• Levels were compared to those in normal pregnancies at corresponding gestational ages.

Main Results:

• Serum relaxin and progesterone levels in hydatidiform mole patients were comparable to normal pregnancies before evacuation.
• Circulating hCG levels were significantly higher in hydatidiform mole patients pre-evacuation.
• Post-evacuation, relaxin levels declined more slowly than hCG and progesterone levels.

Conclusions:

• The slower decline of relaxin post-molar evacuation suggests sustained corpus luteum stimulation by residual hCG.
• An extraluteal source of relaxin in hydatidiform mole pregnancies cannot be ruled out.
• This study provides insights into relaxin dynamics in abnormal pregnancy states.